Pediatrix Medical Group, Inc. - 10-Q Summary (Period Ended September 30, 1996)
Business Context and Reporting Period
This is an unaudited quarterly report (Form 10-Q) for Pediatrix Medical Group, Inc., covering the three and nine months ended September 30, 1996. The Company operates as a neonatology and pediatric physician group, expanding primarily through acquisitions of physician practices and NICUs. As of November 1, 1996, the Company had 14,860,803 shares of common stock outstanding.
Key Financial Metrics
| Metric | 9 Months Ended Sep 30, 1996 | 9 Months Ended Sep 30, 1995 | 3 Months Ended Sep 30, 1996 |
|---|---|---|---|
| Net Patient Service Revenue | $56,339,000 | $30,495,000 | $22,404,000 |
| Net Income | $9,212,000 | $4,396,000 | $3,565,000 |
| Income from Operations | $14,143,000 | $7,047,000 | $5,595,000 |
| Operating Margin | 25.1% | 23.1% | 25.0% |
| Net Cash from Operating Activities | $11,242,000 | $2,053,000 | N/A |
| Cash and Cash Equivalents (End of Period) | $37,962,000 | $44,352,000 | $37,962,000 |
| Total Assets | $152,269,000 | $69,881,000 | $152,269,000 |
| Total Liabilities | $20,286,000 | $7,071,000 | $20,286,000 |
| Working Capital | $80,623,000 | $53,448,000 | $80,623,000 |
Note: All figures in thousands except per share data and percentages.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 84.7% for the nine months ended September 30, 1996, compared to the prior year. Approximately 93.4% of this increase was attributed to new units acquired during the period.
- Profitability: Net income increased 109.6% year-over-year for the nine-month period. Operating margin improved from 23.1% to 25.1% due to volume increases from acquisitions.
- Acquisitions: The Company completed nine acquisitions in the first nine months of 1996, spending approximately $39 million in cash. This included six practices in the first half and three in the third quarter.
- Capital Structure: On August 2, 1996, the Company completed a secondary public offering, issuing 1,755,000 shares for net proceeds of approximately $59.3 million. This significantly boosted liquidity and stockholders' equity.
- Debt: The Company secured a $30 million unsecured revolving credit facility (currently $0 outstanding) and a $3 million mortgage loan (secured by two buildings) during the third quarter.
Outlook, Risks, and Management Commentary
- Liquidity: Management anticipates that funds from operations, the secondary offering, and the credit facility will be sufficient to meet working capital and capital expenditure needs for at least the next twelve months.
- Capital Expenditures: Capital expenditures for the nine months totaled $3.8 million, largely for a new administrative building. Future 1996 expenditures are expected to be $500,000, with 1997 not exceeding $2.0 million.
- Tax Contingency: The IRS has proposed adjustments to tax returns for 1992-1994 that could result in additional taxes of approximately $4.5 million plus interest. Management intends to contest this vigorously and believes the current tax provision is adequate.
- Legal: The Company faces pending medical malpractice claims, which are generally covered by insurance. Management does not expect a material adverse effect on financial condition.
Key Facts for Investor Verification
- Verify the sustainability of the 84.7% revenue growth rate, which is heavily dependent on continued acquisitions rather than organic same-unit growth (which was only 2.7% for the quarter).
- Monitor the resolution of the IRS tax examination regarding the potential $4.5 million liability.
- Assess the integration costs and performance of the nine physician groups acquired in 1996.
- Review the utilization of the $30 million credit facility, which is reserved primarily for future acquisitions.
- Confirm the amortization schedule for goodwill resulting from the purchase method of accounting used for acquisitions.